Skip to main content
Signal8
Launch Terminal
Humer Franz B profile photo

Franz B. Humer

CIK: 0001548072

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Allogene Therapeutics, Inc. logo
ALLO

Allogene Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Allogene Therapeutics, Inc. logo
    ALLO

    Allogene Therapeutics, Inc.

    Jun 18, 2026
    Award(A)

    Restricted Stock Unit

    Direct
    95.4K shares-
  • Allogene Therapeutics, Inc. logo
    ALLO

    Allogene Therapeutics, Inc.

    Jun 18, 2025
    Award(A)

    Restricted Stock Unit

    Direct
    95.4K shares-
  • Allogene Therapeutics, Inc. logo
    ALLO

    Allogene Therapeutics, Inc.

    Dec 5, 2024
    Sale(S)
    Direct
    9.2K shares at avg. $2.16$20K

1-3 of 3

About Humer Franz B

Humer Franz B (SEC CIK 0001548072) files insider reports with the SEC as Director of Allogene Therapeutics, Inc. (ALLO).

Signal8 holds 3 ownership filings by Humer Franz B, all Form 4s, filed between Dec 9, 2024 and Jun 23, 2026. Those filings report 3 transactions, from Dec 5, 2024 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Humer Franz B's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Humer Franz B

  • Jun 18, 2026: Grant or award of ALLO derivative securities (Form 4, code A).
  • Jun 18, 2025: Grant or award of ALLO derivative securities (Form 4, code A).
  • Dec 5, 2024: Open-market sale of ALLO shares (Form 4, code S).

Other insiders filing for Allogene Therapeutics, Inc. (ALLO)

How to read Form 4 transaction codes